Mesenchymal Stromal Cell-derived Extracellular Vesicles in Preclinical Animal Models of Tumor Growth: Systematic Review and Meta-analysis.
Animal studies
Exosomes
Extracellular vesicles
Mesenchymal stromal cells
Metanalysis
Preclinical
Systematic review
Tumor
cancer
Journal
Stem cell reviews and reports
ISSN: 2629-3277
Titre abrégé: Stem Cell Rev Rep
Pays: United States
ID NLM: 101752767
Informations de publication
Date de publication:
03 2022
03 2022
Historique:
accepted:
23
03
2021
pubmed:
17
4
2021
medline:
22
4
2022
entrez:
16
4
2021
Statut:
ppublish
Résumé
Mesenchymal stromal cell derived extracellular vesicles (MSC-EVs) have been implicated in the regulation of tumor growth. Studies remain preclinical with effects ranging from inhibition of tumor growth to cancer progression. A systematic review and meta-analysis is needed to clarify the effect of MSC-EVs on tumor growth to facilitate potential translation to clinical trials. A systematic search of the literature (MEDLINE, Embase, and BIOSIS databases to June 1, 2019) identified all pre-clinical controlled studies investigating the effect of MSC-EVs on tumor growth. Study selection and data extraction were performed in duplicate. Potential risk of bias was assessed using the SYRCLE tool. A random effects meta-analysis of reduction in tumor weight/volume (primary outcome) was performed. We identified 29 articles and 22 reported data on tumor responses that were included for meta-analysis. Studies were associated with unclear risk of bias in a large proportion of domains in accordance with the SYRCLE tool for determining risk of bias in preclinical studies. A high risk of bias was not identified in any study. MSC-EVs had a mixed response on tumor progression with some studies reporting inhibition of tumor growth and others reporting tumor progression. Overall, MSC-EVs exerted a non-significant reduction in tumor growth compared to controls (standardized mean difference (SMD) -0.80, 95 % CI -1.64 to 0.03, p = 0.06, I MSC-EVs are associated with mixed effects on tumor growth in animal models of cancer. In studies where anti-tumor RNAs are packaged in EVs, a significant reduction in tumor growth was observed. Reducing heterogeneity in study design may accelerate our understanding of the potential effects of MSC-EVs on cancer. [274 words] Forest plot of MSC-EV effect on tumor growth accordinggenetic modification of EVs in animal studies identified from a systematicreview of the literature. All cohorts from studies with multiple interventiongroups are presented separately with control groups divided equally among thegroups. M, modified; H, hypoxia.
Sections du résumé
BACKGROUND
Mesenchymal stromal cell derived extracellular vesicles (MSC-EVs) have been implicated in the regulation of tumor growth. Studies remain preclinical with effects ranging from inhibition of tumor growth to cancer progression. A systematic review and meta-analysis is needed to clarify the effect of MSC-EVs on tumor growth to facilitate potential translation to clinical trials.
METHODS
A systematic search of the literature (MEDLINE, Embase, and BIOSIS databases to June 1, 2019) identified all pre-clinical controlled studies investigating the effect of MSC-EVs on tumor growth. Study selection and data extraction were performed in duplicate. Potential risk of bias was assessed using the SYRCLE tool. A random effects meta-analysis of reduction in tumor weight/volume (primary outcome) was performed.
RESULTS
We identified 29 articles and 22 reported data on tumor responses that were included for meta-analysis. Studies were associated with unclear risk of bias in a large proportion of domains in accordance with the SYRCLE tool for determining risk of bias in preclinical studies. A high risk of bias was not identified in any study. MSC-EVs had a mixed response on tumor progression with some studies reporting inhibition of tumor growth and others reporting tumor progression. Overall, MSC-EVs exerted a non-significant reduction in tumor growth compared to controls (standardized mean difference (SMD) -0.80, 95 % CI -1.64 to 0.03, p = 0.06, I
CONCLUSIONS
MSC-EVs are associated with mixed effects on tumor growth in animal models of cancer. In studies where anti-tumor RNAs are packaged in EVs, a significant reduction in tumor growth was observed. Reducing heterogeneity in study design may accelerate our understanding of the potential effects of MSC-EVs on cancer. [274 words] Forest plot of MSC-EV effect on tumor growth accordinggenetic modification of EVs in animal studies identified from a systematicreview of the literature. All cohorts from studies with multiple interventiongroups are presented separately with control groups divided equally among thegroups. M, modified; H, hypoxia.
Identifiants
pubmed: 33860455
doi: 10.1007/s12015-021-10163-5
pii: 10.1007/s12015-021-10163-5
doi:
Types de publication
Journal Article
Meta-Analysis
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
993-1006Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Tieu, A., Lalu, M. M., Slobodian, M., et al. (2020). An analysis of mesenchymal stem cell-derived extracellular vesicles for preclinical use. ACS Nano, 14(8), 9728–9743. https://doi.org/10.1021/acsnano.0c01363 .
doi: 10.1021/acsnano.0c01363
pubmed: 32697573
Ding, D.-C., Shyu, W.-C., & Lin, S.-Z. (2011). Mesenchymal stem cells. Cell Transplant, 20(1), 5–14. https://doi.org/10.3727/096368910X .
doi: 10.3727/096368910X
pubmed: 21396235
Allan, D., Tieu, A., Lalu, M., & Burger, D. (2020). Mesenchymal stromal cell-derived extracellular vesicles for regenerative therapy and immune modulation: Progress and challenges toward clinical application. Stem Cells Translational Medicine, 9(1), 39–46. https://doi.org/10.1002/sctm.19-0114 .
doi: 10.1002/sctm.19-0114
pubmed: 31411820
Tieu, A., Slobodian, M., Fergusson, D. A., et al. (2019). Methods and efficacy of extracellular vesicles derived from mesenchymal stromal cells in animal models of disease: A preclinical systematic review protocol. Systematic Reviews, 8(1), 322. https://doi.org/10.1186/s13643-019-1242-y .
doi: 10.1186/s13643-019-1242-y
pubmed: 31831057
pmcid: 6909572
Oloyo, A. K., Ambele, M. A., & Pepper, M. S. (2018). Contrasting views on the role of mesenchymal stromal/stem cells in tumour growth: a systematic review of experimental design. Advances in Experimental Medicine and Biology, 1083, 103–124. https://doi.org/10.1007/5584_2017_118 .
doi: 10.1007/5584_2017_118
pubmed: 29139088
Lang, F. M., Hossain, A., Gumin, J., et al. (2018). Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas. Neuro-Oncology. https://doi.org/10.1093/neuonc/nox152 .
doi: 10.1093/neuonc/nox152
pubmed: 29016987
pmcid: 6217277
(2019) P. G. Concise review: Adipose-derived stem cells (ASCs) and adipocyte-secreted exosomal microrna (A-SE-miR) modulate cancer growth and promote wound repair. Journal of Clinical Medicine. 8(6), 855. https://doi.org/10.3390/jcm8060855
Kordelas, L., Rebmann, V., Ludwig, A. K., et al. (2014). MSC-derived exosomes: A novel tool to treat therapy-refractory graft-versus-host disease. Leukemia, 28(4), 970–973. https://doi.org/10.1038/leu.2014.41 .
doi: 10.1038/leu.2014.41
pubmed: 24445866
Chen, W., Huang, Y., Han, J., et al. (2016). Immunomodulatory effects of mesenchymal stromal cells-derived exosome. The Journal of Immunology. https://doi.org/10.1007/s12026-016-8798-6 .
doi: 10.1007/s12026-016-8798-6
pubmed: 28031334
pmcid: 5026029
van Niel, G., D’Angelo, G., & Raposo, G. (2018). Shedding light on the cell biology of extracellular vesicles. Nature Reviews Molecular Cell Biology, 19(4), 213–228. https://doi.org/10.1038/nrm.2017.125 .
doi: 10.1038/nrm.2017.125
pubmed: 29339798
Yáñez-Mó, M., Siljander, P. R. M., Andreu, Z., et al. (2015). Biological properties of extracellular vesicles and their physiological functions. Journal of Extracellular Vesicles, 4, 27066. https://doi.org/10.3402/jev.v4.27066 .
doi: 10.3402/jev.v4.27066
pubmed: 25979354
Kalluri, H., Kolli, C. S., & Banga, A. K. (2011). Characterization of microchannels created by metal microneedles: Formation and closure. American Association of Pharmaceutical Scientists Journal. https://doi.org/10.1208/s12248-011-9288-3 .
doi: 10.1208/s12248-011-9288-3
pubmed: 21732220
pmcid: 3160154
Batrakova, E. V., & Kim, M. S. (2015). Using exosomes, naturally-equipped nanocarriers, for drug delivery. Journal of Controlled Release. https://doi.org/10.1016/j.jconrel.2015.07.030 .
doi: 10.1016/j.jconrel.2015.07.030
pubmed: 26241750
pmcid: 4656109
Z, Z. G. (2019). Exosomes - beyond stem cells for restorative therapy in stroke and neurological injury. Nature Reviews Neurology, 15(4), 193–203. https://doi.org/10.1038/s41582-018-0126-4 .
doi: 10.1038/s41582-018-0126-4
L, P. G. B., A-M, S., et al. (2018). Mesenchymal stem cells-derived exosomes for wound regeneration. Advances in Experimental Medicine and Biology, 1119, 119–131. https://doi.org/10.1007/5584_2018_251 .
doi: 10.1007/5584_2018_251
Yaghoubi, Y., Movassaghpour, A., Zamani, M., Talebi, M., Mehdizadeh, A., & Yousefi, M. (2019). Human umbilical cord mesenchymal stem cells derived-exosomes in diseases treatment. Life Sciences, 233, 116733. https://doi.org/10.1016/j.lfs.2019.116733
Lopatina, T., Grange, C., Fonsato, V., et al. (2019). Extracellular vesicles from human liver stem cells inhibit tumor angiogenesis. International Journal of Cancer. https://doi.org/10.1002/ijc.31796 .
doi: 10.1002/ijc.31796
pubmed: 30110127
Dong, L., Pu, Y., Zhang, L., et al. (2018). Human umbilical cord mesenchymal stem cell-derived extracellular vesicles promote lung adenocarcinoma growth by transferring miR-410 article. Cell Death and Disease. https://doi.org/10.1038/s41419-018-0323-5 .
doi: 10.1038/s41419-018-0323-5
pubmed: 30385753
pmcid: 6212494
Rosenberger, L., Ezquer, M., Lillo-Vera, F., et al. (2019). Stem cell exosomes inhibit angiogenesis and tumor growth of oral squamous cell carcinoma. Scientific Reports. https://doi.org/10.1038/s41598-018-36855-6 .
doi: 10.1038/s41598-018-36855-6
pubmed: 30679544
pmcid: 6345809
Bruno, S., Collino, F., Deregibus, M. C., Grange, C., Tetta, C., & Camussi, G. (2013). Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth. Stem Cells and Development. https://doi.org/10.1089/scd.2012.0304 .
doi: 10.1089/scd.2012.0304
pubmed: 23034046
Kalimuthu, S., Gangadaran, P., Li, X. J., et al. (2016). In Vivo therapeutic potential of mesenchymal stem cell-derived extracellular vesicles with optical imaging reporter in tumor mice model. Scientific Reports. https://doi.org/10.1038/srep30418 .
doi: 10.1038/srep30418
pubmed: 27452924
pmcid: 4958922
Alzahrani, F. A., El-Magd, M. A., Abdelfattah-Hassan, A., et al. (2018). Potential effect of exosomes derived from cancer stem cells and MSCs on progression of DEN-Induced HCC in Rats. Stem Cells International. https://doi.org/10.1155/2018/8058979 .
doi: 10.1155/2018/8058979
pubmed: 30224923
pmcid: 6129855
Raposo, G., & Stoorvogel, W. (2013). Extracellular vesicles: Exosomes, microvesicles, and friends. Journal of Cell Biology. https://doi.org/10.1083/jcb.201211138 .
doi: 10.1083/jcb.201211138
Moher, D., Liberati, A., Tetzlaff, J., et al. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6(7), e1000097. https://doi.org/10.1371/journal.pmed.1000097 .
doi: 10.1371/journal.pmed.1000097
pubmed: 2707599
pmcid: 2707599
McGowan, J., Sampson, M., Salzwedel, D. M., Cogo, E., Foerster, V., & Lefebvre, C. (2016). PRESS peer review of electronic search strategies: 2015 guideline statement. Journal of Clinical Epidemiology, 75, 40–46. https://doi.org/10.1016/j.jclinepi.2016.01.021 .
doi: 10.1016/j.jclinepi.2016.01.021
pubmed: 27005575
Viswanathan, S., Shi, Y., Galipeau, J., et al. (2019). Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy, 21(10), 1019–1024. https://doi.org/10.1016/j.jcyt.2019.08.002 .
doi: 10.1016/j.jcyt.2019.08.002
pubmed: 31526643
Théry, C., Witwer, K. W., Aikawa, E., et al. (2018). Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. Journal of Extracellular Vesicles, 7(1), 1535750. https://doi.org/10.1080/20013078.2018.1535750 .
doi: 10.1080/20013078.2018.1535750
pubmed: 30637094
pmcid: 6322352
Hooijmans, C. R., Rovers, M. M., De Vries, R. B. M., Leenaars, M., Ritskes-Hoitinga, M., & Langendam, M. W. (2014). SYRCLE’s risk of bias tool for animal studies. BMC Medical Research Methodology, 14, 43. https://doi.org/10.1186/1471-2288-14-43 .
doi: 10.1186/1471-2288-14-43
pubmed: 24667063
pmcid: 4230647
DerSimonian, R., & Laird, N. (1986). Meta-analysis in clinical trials. Controlled Clinical Trials. https://doi.org/10.1016/0197-2456(86)90046-2 .
doi: 10.1016/0197-2456(86)90046-2
pubmed: 3802833
(2019) Cochrane Handbook for Systematic Reviews of Interventions. https://doi.org/10.1002/9781119536604 .
Higgins, J. P. T., Thomas, J., Chandler, J., Cumpston, M., Li, T., & Page, M. J. W. V. (2019). Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane database Syst Rev. ;10:ED000142. https://doi.org/10.1002/14651858.ED000142 .
Iranpour, S., Hosseinzadeh, A., & Alipour, A. (2019). Efficacy of miltefosine compared with glucantime for the treatment of cutaneous leishmaniasis: a systematic review and meta-analysis. Epidemiology and Health, 41, e2019011. https://doi.org/10.4178/epih.e2019011 .
doi: 10.4178/epih.e2019011
pubmed: 30999735
pmcid: 6635659
Ji, R., Zhang, B., Zhang, X., et al. (2015). Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer. Cell Cycle. https://doi.org/10.1080/15384101.2015.1005530 .
doi: 10.1080/15384101.2015.1005530
pubmed: 26091251
pmcid: 4613597
Du, T., Ju, G., Wu, S., et al. (2014). Microvesicles derived from human Wharton’s jelly mesenchymal stem cells promote human renal cancer cell growth and aggressiveness through induction of hepatocyte growth factor. PLoS One. https://doi.org/10.1371/journal.pone.0096836 .
doi: 10.1371/journal.pone.0096836
pubmed: 25919136
pmcid: 4281229
Lee, J. K., Park, S. R., Jung, B. K., et al. (2013). Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One. https://doi.org/10.1371/journal.pone.0084256 .
doi: 10.1371/journal.pone.0084256
pubmed: 24392023
pmcid: 3877376
Wu, S., Ju, G. Q., Du, T., Zhu, Y. J., & Liu, G. H. (2013). Microvesicles derived from human umbilical cord wharton’s jelly mesenchymal stem cells attenuate bladder tumor cell growth in vitro and in vivo. PLoS One. https://doi.org/10.1371/journal.pone.0061366 .
doi: 10.1371/journal.pone.0061366
pubmed: 24392036
pmcid: 3877400
Katakowski, M., Buller, B., Zheng, X., et al. (2013). Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Letters. https://doi.org/10.1016/j.canlet.2013.02.019 .
doi: 10.1016/j.canlet.2013.02.019
pubmed: 23419525
pmcid: 3665755
Zhu, W., Huang, L., Li, Y., et al. (2012). Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo. Cancer Letters. https://doi.org/10.1016/j.canlet.2011.10.002 .
doi: 10.1016/j.canlet.2011.10.002
pubmed: 23266572
O’Brien, K. P., Khan, S., Gilligan, K. E., et al. (2018). Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379. Oncogene. https://doi.org/10.1038/s41388-017-0116-9 .
doi: 10.1038/s41388-017-0116-9
pubmed: 30171258
pmcid: 6358506
Grigorian-Shamagian, L., Fereydooni, S., Liu, W., Echavez, A., & Marbán, E. (2017). Harnessing the heart’s resistance to malignant tumors: Cardiacderived extracellular vesicles decrease fibrosarcoma growth and leukemia-related mortality in rodents. Oncotarget. https://doi.org/10.18632/oncotarget.20454 .
doi: 10.18632/oncotarget.20454
pubmed: 29245929
pmcid: 5725120
Shi, S., Zhang, Q., Xia, Y., et al. (2016). Mesenchymal stem cell-derived exosomes facilitate nasopharyngeal carcinoma progression. Am J Cancer Res. 6(2):459-72.
Ko, S. F., Yip, H. K., Zhen, Y. Y., et al. (2015). Adipose-derived mesenchymal stem cell exosomes suppress hepatocellular carcinoma growth in a rat model: apparent diffusion coefficient, natural killer T-cell responses, and histopathological features. Stem Cells International. https://doi.org/10.1155/2015/853506 .
doi: 10.1155/2015/853506
pubmed: 26345219
pmcid: 4545422
Roccaro, A. M., Sacco, A., Maiso, P., et al. (2013). BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. Journal of Clinical Investigation. https://doi.org/10.1172/JCI66517 .
doi: 10.1172/JCI66517
Ren, W., Hou, J., Yang, C., et al. (2019). Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization via miR-21-5p delivery. Journal of Experimental & Clinical Cancer Research. https://doi.org/10.1186/s13046-019-1027-0 .
doi: 10.1186/s13046-019-1027-0
pubmed: 31350313
Lin, S., Zhu, B., Huang, G., Zeng, Q., & Wang, C. (2019). Microvesicles derived from human bone marrow mesenchymal stem cells promote U2OS cell growth under hypoxia: the role of PI3K/AKT and HIF-1α. Human Cell. https://doi.org/10.1007/s13577-018-0224-z .
doi: 10.1007/s13577-018-0224-z
pubmed: 31784953
Ding, Y., Cao, F., Sun, H., et al. (2019). Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression. Cancer Letters. https://doi.org/10.1016/j.canlet.2018.10.039 .
doi: 10.1016/j.canlet.2018.10.039
pubmed: 31837444
Shamili, F. H., Bayegi, H. R., Salmasi, Z., et al. (2018). Exosomes derived from TRAIL-engineered mesenchymal stem cells with effective anti-tumor activity in a mouse melanoma model. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2018.07.067 .
doi: 10.1016/j.ijpharm.2018.07.067
pubmed: 30075248
Naseri, Z., Oskuee, R. K., Jaafari, M. R., & Moghadam, M. F. (2018). Exosome-mediated delivery of functionally active miRNA-142-3p inhibitor reduces tumorigenicity of breast cancer in vitro and in vivo. International Journal of Nanomedicine. https://doi.org/10.2147/IJN.S182384 .
doi: 10.2147/IJN.S182384
pubmed: 30538455
pmcid: 6251455
Mendt, M., Kamerkar, S., Sugimoto, H., et al. (2018). Generation and testing of clinical-grade exosomes for pancreatic cancer. JCI Insight. https://doi.org/10.1172/jci.insight.99263 .
doi: 10.1172/jci.insight.99263
pubmed: 29669940
pmcid: 5931131
Li, H., Yang, C., Shi, Y., & Zhao, L. (2018). Exosomes derived from siRNA against GRP78 modified bone-marrow-derived mesenchymal stem cells suppress Sorafenib resistance in hepatocellular carcinoma. Journal of Nanobiotechnology. https://doi.org/10.1186/s12951-018-0429-z .
doi: 10.1186/s12951-018-0429-z
pubmed: 30594254
pmcid: 6311082
Kim, R., Lee, S., Lee, J., et al. (2018). Exosomes derived from microRNA-584 transfected mesenchymal stem cells: Novel alternative therapeutic vehicles for cancer therapy. BMB Reports. https://doi.org/10.5483/BMBREP.2018.51.8.105 .
doi: 10.5483/BMBREP.2018.51.8.105
pubmed: 30591093
pmcid: 6330941
Kamerkar, S., Lebleu, V. S., Sugimoto, H., et al. (2017). Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. https://doi.org/10.1038/nature22341 .
doi: 10.1038/nature22341
pubmed: 28607485
pmcid: 5538883
Vallabhaneni, K. C., Penfornis, P., Dhule, S., et al. (2015). Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites. Oncotarget. https://doi.org/10.18632/oncotarget.3211 .
doi: 10.18632/oncotarget.3211
pubmed: 25669974
Lou, G., Song, X., Yang, F., et al. (2015). Exosomes derived from MIR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. Journal of Hematology & Oncology. https://doi.org/10.1186/s13045-015-0220-7 .
doi: 10.1186/s13045-015-0220-7
Henderson, V. C., Kimmelman, J., Fergusson, D., Grimshaw, J. M., & Hackam, D. G. (2013). Threats to validity in the design and conduct of preclinical efficacy studies: a systematic review of guidelines for in vivo animal experiments. PLoS Medicine, 10(7), e1001489. https://doi.org/10.1371/journal.pmed.1001489 .
doi: 10.1371/journal.pmed.1001489
pubmed: 23935460
pmcid: 3720257
Busatto, S., Vilanilam, G., Ticer, T., et al. (2018). Tangential flow filtration for highly efficient concentration of extracellular vesicles from large volumes of fluid. Cells. https://doi.org/10.3390/cells7120273 .
doi: 10.3390/cells7120273
pubmed: 30558352
pmcid: 6315734
Mount, N. M., Ward, S. J., Kefalas, P., & Hyllner, J. (2015). Cell-based therapy technology classifications and translational challenges. Philosophical Transactions of the Royal Society B. https://doi.org/10.1098/rstb.2015.0017 .
doi: 10.1098/rstb.2015.0017